New heart failure device is tested

Oct 17, 2006

Physicians at 50 U.S. medical facilities are taking part in a multinational clinical trial of a device designed to help heart failure victims.

The Optimizer System is an implantable pulse generator that delivers electrical impulses to the heart for treatment of moderate-to-severe heart failure.

Physicians at the University of Texas Southwestern Medical Center say unlike other heart-failure devices, the Optimizer works by modulating the strength of the heart's contractions rather than by controlling its rhythm.

"The Optimizer could benefit up to two-thirds of advanced heart-failure patients who may not qualify for other kinds of therapy," said Dr. Jose Joglar, co-investigator of the study and associate professor of medicine in the University of Texas Southwestern's Heart, Lung and Vascular Center.

Heart failure afflicts more than 5 million people in the United States and an estimated 15 million people worldwide. It is one of the most common causes of hospitalization. In patients with heart failure, the heart muscle is too weak or damaged to pump enough blood through the body.

Copyright 2006 by United Press International

Explore further: Simulation-based training improves endoscopy execution

add to favorites email to friend print save as pdf

Related Stories

Lab sets a new record for creating heralded photons

May 20, 2013

(Phys.org) —Entanglement, by general consensus of physicists, is the weirdest part of quantum science. To say that two particles, A and B, are entangled means that they are actually two parts of an inseparable ...

German energy shift faces headwinds

May 19, 2013

Tense engineers have their eyes peeled on complex colour-coded diagrams on a wall-sized screen that makes their control room look like the inside of a spaceship.

Continuous monitoring of UV exposure

Apr 29, 2013

UV lamps are used to cure coatings and adhesives in many industrial manufacturing processes. And special sensors are used to measure the intensity of the UV light applied to these surfaces. But because these ...

Dealing with power outages more efficiently

Nov 01, 2012

When there is a power failure, the utility companies, public officials and emergency services must work together quickly. Researchers have created a new planning software product that enables all participants ...

Synchrotrons play role in Nobel Prize research

Oct 25, 2012

Synchrotrons played a key role in the research that won Brian Kobilka, a professor and chair of Molecular and Cellular Physiology at the Stanford School of Medicine, the 2012 Nobel Prize in chemistry on Wednesday.

Texas AgriLife Research scientists making better melons

Sep 20, 2011

With the extended statewide dry spell, researchers at the Texas AgriLife Research and Extension Center in Uvalde and elsewhere have been focusing their attention on improving varieties of more drought-tolerant crops, particularly ...

Recommended for you

Using feminist theory to understand male rape

1 hour ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0